Latest for CDKL5 Deficiency Disorder
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Early Check: Expanded Screening in Newborns (RTI International)ClinicalTrials.gov
- Who can joinWho can join changed for Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With… (Phase 3, Zogenix)ClinicalTrials.gov
More about CDKL5 Deficiency Disorder
The hallmark feature is extremely early seizure onset combined with profound developmental impairment. Most people with CDKL5 continue to have multiple seizures daily despite anti-seizure medications. Additional challenges include movement disorders, sleep problems, and feeding difficulties that significantly impact quality of life for individuals and families.
Keep reading about CDKL5 Deficiency Disorder
Diagnosis requires genetic testing to identify CDKL5 mutations. While there is no cure, treatment focuses on seizure management, physical and occupational therapy, and supportive care to maximize quality of life. Ztalmy (ganaxolone), approved in March 2022, is the only medicine the FDA has approved for seizures in CDKL5 deficiency disorder, for people 2 years and older.
What are the symptoms of CDKL5 Deficiency Disorder?
These are common symptoms of CDKL5 Deficiency Disorder, and how strong they are varies from person to person.
- Severe seizures starting in infancy (usually by 3 months of age)
- Profound developmental delays affecting movement, speech, and cognition
- Vision problems including reduced eye focus and abnormal eye movements
- Sleep disruption with inability to sleep through the night
- Involuntary movements such as hand and leg jerking or dystonia
- Feeding difficulties and gastrointestinal problems like reflux and constipation
Who gets CDKL5 Deficiency Disorder?
CDKL5 is an X-linked condition affecting both males and females, though females are diagnosed about 4 times more often. Seizures begin within the first year of life, typically by 3 months. Males who inherit the condition often experience more severe developmental delays. About 99% of cases arise from new genetic mutations rather than being inherited from parents.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for CDKL5 Deficiency Disorder?
There is currently 1 FDA-approved medication for CDKL5 Deficiency Disorder.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for CDKL5 Deficiency Disorder treatment
Charity funds and drugmaker programs for CDKL5 Deficiency Disorder, checked at the source.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for CDKL5 Deficiency Disorder
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
The CDKL5 gene page lists every condition Orphanet links to the gene and the open trials that name it.
Finding labs...
Trusted CDKL5 Deficiency Disorder resources
Reputable organizations and medical references for learning more about CDKL5 Deficiency Disorder, including disease registries, foundation resources, and clinical guidelines.